Login / Signup

Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort.

Alex HandyAmitava BanerjeeAngela M WoodCaroline DaleCathie L M SudlowChristopher TomlinsonDaniel M BeanJohan H ThygesenMehrdad A MizaniMichail KatsoulisRohan TakharSam HollingsSpiros DenaxasVenexia WalkerRichard James Butler DobsonReecha Sofatnull null
Published in: Heart (British Cardiac Society) (2022)
Pre-existing AT use may be associated with lower odds of COVID-19 death and, while not evidence of causality, provides further incentive to improve AT coverage for eligible individuals with AF.
Keyphrases